After Trump's announcement, Commerce Secretary Howard Lutnick told CNBC that details on pharmaceutical tariffs would come at the end of July.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

President Donald Trump said he planned to implement a 50% duty on copper imports as part of a set of looming sectoral tariffs ...

Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On June 22, Eli Lilly and ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

U.S. President Donald Trump on Tuesday said he plans to announce tariffs on imported pharmaceuticals which could reach 200% ...

Wall Street ended mixed a day after a broad sell-off in response to the Trump administration setting new tariffs on more than ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Shares in drug companies such as Eli Lilly dropped from their session highs Tuesday afternoon after President Donald Trump said U.S. tariffs on imported pharmaceuticals could be as high as 200%.

Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

Since then, Trump has said the investments have swelled to $14 trillion, or roughly half of the nation's annual gross ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...